Skip to content

Application of intense pulsed light in the treatment of demodex blepharitis

Application of intense pulsed light in the treatment of demodex blepharitis

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056259
Enrollment
Unknown
Registered
2022-02-03
Start date
2021-02-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

demodex blepharitis

Interventions

IPL group:Patients were treated with intense pulsed light once every month for a total of 3 times
4-terpineol wipes set:Use acarus-removing wipes to clean the upper and lower eyelid margins once in the morning and once in the evening. Gently wipe the upper and lower eyelid margins from the inner c

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. There are different degrees of ocular surface discomfort symptoms, including dry eyes, itching eyes, foreign body sensation, burning sensation, foamy secretions, etc. Or repeated attacks of sty, conjunctivitis, blepharitis, etc.; 2. According to the slit lamp examination, there were different degrees of cuff like scales of eyelashes, and the eyelashes were taken out and examined under light microscope. There were no less than 3 demodex mites in each eye; 3. No medication or physical therapy has been used in the past 3 months.

Exclusion criteria

Exclusion criteria: 1. Experienced eye trauma, endophthalmitis, infectious or infectious ocular surface disease, or eye surgery within 6 months; 2. Systemic diseases that can cause dry eyes; 3. Lacrimal plug implantation or lacrimal canaloplasty was performed within 3 months; 4. The presence of ocular surface abnormalities in any eye that may affect corneal integrity or eyelid abnormalities that may affect eyelid function; 5. Participate in other ophthalmic clinical trials involving drug therapy or medical devices within 30 days prior to baseline examination; 6. Patients during pregnancy and lactation; 7. There are whole-body or local diseases that researchers consider unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Eye symptoms;Number of demodex mites in each eye;

Countries

China

Contacts

Public ContactQing Zhang

The Second Affiliated Hospital of Anhui Medical University

zhangqing@ahmu.edu.com+86 13965103796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026